We received an investment from Kyoto University Innovation Capital Co., Ltd. and a press release was made. It was also published in the Nihon Keizai Shimbun (April 6th).
Kyoto University based drug discovery startup BTB Drug Development Research Center (Kyoto City) has raised \100 million from venture capital firms associated with Kyoto University. This will be used for drug research and development. BTB are developing painkillers that can reduce postoperative pain, and will simultaneously begin clinical trials within Japan and overseas in FY2022.